BPC-157 and VIP Interaction
BPC-157 and VIP have a compatible interaction with 90% confidence. No known negative interactions; different mechanisms. These compounds primarily affect different organ systems.
Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
View full profileVIP
Vasoactive Intestinal Peptide | Neuropeptide
VIP binds to VPAC1 and VPAC2 G protein-coupled receptors, activating adenylyl cyclase and increasing intracellular cAMP and PKA activity. This triggers phosphorylation of CREB and other transcription factors.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with VIP?
Yes, BPC-157 and VIP can generally be taken together. No known negative interactions; different mechanisms.
Is BPC-157 and VIP safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between BPC-157 and VIP?
No known negative interactions; different mechanisms. This assessment has 90% confidence and is based on documented research data.
How should I time BPC-157 and VIP?
BPC-157 has a half-life of <30 minutes and VIP has a half-life of 1-2 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.